Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery

J Eur Acad Dermatol Venereol. 2012 Jul;26(7):838-43. doi: 10.1111/j.1468-3083.2011.04165.x. Epub 2011 Jun 25.

Abstract

Background: Basal cell carcinoma (BCC) is a non-melanocytic skin tumour with a high risk of recurrence after incomplete treatment, especially the aggressive subtypes (basosquamous, micronodular and morphea BCC). The percentage of recurrence also depends on the anatomical site of the tumour. Nose-cheek fold, paranasal fold, retroauricular fold and internal canthus are considered to be critical sites.

Objective: The aim of this study was to report on recurrence rates for BCC treated with Mohs micrographic surgery (MMS).

Material and methods: We retrospectively studied 350 BCCs of the head region treated with MMS. Results were analysed with chi-squared test and Fisher test and were considered significant when P value was ≤0.05.

Results: In our study, the percentage of BCC recurrence rate after MMS was of 3.4% for primary BCC and 4.9% for recurrent BCC; these were similar to the recurrence rates reported in the literature.

Conclusions: Low recurrence rate can be achieved when treated with MMS; it is the treatment of choice for many BCC of the head. Aggressive histopathological subtypes, critical head sites and recurrence after incomplete excision are the most important indications for MMS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Basal Cell / surgery*
  • Female
  • Head / pathology*
  • Humans
  • Male
  • Mohs Surgery*
  • Neoplasm Recurrence, Local
  • Retrospective Studies
  • Skin Neoplasms / surgery*
  • Treatment Outcome